Acute Exacerbations: Predictors of Poor Outcomes in COPD
Industry Webcast Sponsored by AstraZeneca; Not for CME/CE Credit
This program will examine the risk factors associated with COPD exacerbations and the potential impacts of acute exacerbations on patient health, quality of life, and mortality. An understanding of COPD exacerbations and the range of consequences highlights opportunities to optimize COPD management earlier in the course of disease.
This content is developed exclusively by or on behalf of the industry sponsor; it is not reviewed or associated with Pri-Med and Pri-Med does not endorse or sanction any third-party content.